Company intelligence / Profile preview

Neurolens

Coppell, Texas, United Statesneurolens.com ↗

Ownership: Private
Employees: ~174
Development stage: Commercial

Overview

Neurolens has commercialized its patented Contoured Prism lens technology, which is clinically shown to relieve symptoms such as headaches, neck/shoulder pain, and eyestrain in patients with binocular vision dysfunction. A parallel arm study showed that after seven days of lens wear, the average improvement in reading speed with Neurolenses was almost 70% higher than with other premium lens designs. The company reports dramatic symptom relief in 93% of patients.

Therapeutic areas: OphthalmologyNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

MVM PartnersFalcon Vision/KKR

Beyond the preview

Go deeper on Neurolens.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurolens.

Explore the full profile